PAXILLIN

PAXILLIN

Pack Size Cat No
0.2 mL Concentrate RM028-AA
1.0 mL Concentrate RM028-CC
3.0 mL Predilute RM028-3D
6.0 mL Predilute RM028-6D
Categories: ,

Description

Paxillin a cytoskeletal focal adhesion adaptor protein is involved in multiple signal transductions. It has the capacity to enhance the adhesion between tumor cells and the surrounding cells and molecules, thus promoting the migration and invasion capacities of tumor cells. Numerous studies reported that the abnormal expression of Paxillin in tumor tissues was closely related with tumorogenesis and cancer metastasis. In general, higher expression of Paxillin was accompanied with a greater likelihood of malignant behavior. The effect of Paxillin on cell proliferation was mainly regulated by tyrosine or serine phosphorylation. Paxillin play an important role in the development and metastasis of colorectal cancer.

Specifications

Alternative Name PXN, entrez:5829, paxillin
Species Rabbit
Clone Y113
Isotype Rabbit IgG
Dilution Range Assay dependent
Species Reactivity Human, Cynomolgus Monkey, Rabbit
Application IHC
Cell Localization Cytoplasm & Cell junction
Positive Control Breast Carcinoma

DataSheet & SDS

Download Data Sheet
Download SDS Sheet

References

1. Cheng-jin Zhao et al, Expression of Paxillin is Correlated with Clinical Prognosis in Colorectal Cancer Patients, Med Sci Monit, 2015 July 10.

2. Saurabh Shekhar et al, Evaluation of paxillin expression in patients with oral squamous cell carcinoma: An Immunohistochemical study, J Oral Maxillofac Pathol, 2017 May-Aug, (V) 21,  318–319.

3. Sarah M. Short BS et al, The Expression of the Cytoskeletal Focal Adhesion Protein Paxillin in Breast Cancer Correlates with HER2 Overexpression and May Help Predict Response to Chemotherapy: A Retrospective Immunohistochemical Study, The Breast Journal, 2007 March/April.

Request More Information

We would like to get in touch with you for any enquiry related to Pricing/Offer/Product Quotation, Order Support, and Technical Support.

 

Subject *

Name *

Email *

Phone No

Organization

Attach File, if any

Comments